Stage III Prostate Carcinoma
2 clinical trials · Condition
◉ Watch Stage III Prostate Carcinoma
| Record | Firm | Date |
|---|---|---|
| Dose Finding Safety Study of VAL201 in Cancer Patients (NCT02280317) | ValiRx Plc | 2014-10-01 |
| Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer (NCT01938339) | Seoul National University Hospital | 2012-05-01 |
Track Stage III Prostate Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.